Skip to main content
N

NKY Medical Holdings Ltd. — Investor Relations & Filings

Ticker · 300109 LEI · 300300WRQJEGI6005N04 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,610 across all filing types
Latest filing 2026-04-23 Annual Report
Country CN China
Listing Shenzhen Stock Exchange 300109

About NKY Medical Holdings Ltd.

https://www.nkygroup.cn、www.boai-nky.com

NKY Medical Holdings Ltd. specializes in the research, development, and production of polyvinylpyrrolidone (PVP) series products and specialty polymers. The company’s core portfolio includes PVP K-series, Povidone-Iodine (PVP-I), Crospovidone (PVPP), and Vinylpyrrolidone/Vinyl Acetate (PVP/VA) copolymers. These products function as essential excipients, binders, and disintegrants within the pharmaceutical sector, and are also utilized in cosmetics, food processing, and industrial applications such as coatings and adhesives. In addition to its chemical manufacturing operations, the company provides medical services and high-end medical consumables. NKY focuses on high-purity chemical solutions and maintains international quality standards, including GMP and ISO certifications, to support its global supply chain and technical service offerings.

Recent filings

Filing Released Lang Actions
2025年财务决算报告
Annual Report Classification · 1% confidence The document is titled '2025年度财务决算报告' (2025 Annual Financial Final Accounts Report) for '博爱新开源医疗科技集团股份有限公司'. It contains comprehensive financial statements (Balance Sheet, Income Statement, Cash Flow Statement), detailed analysis of financial performance, and notes on related party transactions for the full fiscal year 2025. While it is a report for the full year, it is presented as a 'Financial Final Accounts Report' (财务决算报告) rather than the full statutory Annual Report (10-K) which typically includes auditor opinions, corporate governance sections, and extensive management discussion and analysis. In the context of Chinese corporate filings, this is a standard comprehensive financial report for the fiscal year, which fits the definition of an Annual Report (10-K) as it provides the full financial performance for the year. FY 2025
2026-04-23 Chinese
第五届董事会第二十三次会议决议公告
Regulatory Filings Classification · 1% confidence The document is a Chinese board resolution announcement (“董事会会议决议公告”) summarizing the Fifth Board’s meeting decisions on the 2025 annual report, dividend, auditor reappointment, capital changes, ESG report, committee adjustments, share repurchase proposals, board nominations, etc. It is not the annual report itself, nor a meeting transcript, change-of-management notice, or earnings release. It serves as a regulatory announcement of board resolutions across diverse items without fitting a more specific category, so it defaults to a general regulatory filing (RNS).
2026-04-23 Chinese
关于会计师事务所2025年度履职情况的评估报告
Audit Report / Information Classification · 1% confidence The document is an evaluation report prepared by the Board on the performance of its appointed accounting firm (audit firm) for the 2025 audit, describing audit scope, procedures, adherence to CPA standards, and issuance of an unqualified audit opinion. This is a standalone audit-related report, not a full annual report or earnings release. It fits the “Audit Report / Information” category.
2026-04-23 Chinese
董事会关于独立董事独立性情况的专项意见
Governance Information Classification · 1% confidence The document is a board-issued opinion on the annual independence assessment of the company’s independent directors. This is not a change in management nor a financial report or earnings release. It concerns governance practices and compliance with independent director rules, fitting the Governance Information category (CGR).
2026-04-23 Chinese
关于续聘2026年度会计师事务所的公告
Regulatory Filings Classification · 1% confidence The document is a formal announcement by the company’s board to shareholders regarding the proposed re-appointment of its external audit firm for fiscal 2026. It does not contain an actual audit report or financial statements, nor is it an earnings release, dividend notice, management change, or proxy solicitation. It is a standard regulatory announcement that does not fit any of the more specific categories, making it a fallback Regulatory Filing (RNS).
2026-04-23 Chinese
关于举行2025年年度网上业绩说明会的公告
Investor Presentation Classification · 1% confidence The document is an announcement by the company about holding an online performance briefing (业绩说明会) to explain the 2025 annual report to investors, with details on date, time, platform, participants, and question solicitation. This is not the annual report itself (10-K) nor a proxy, dividend, or AGM notice. It is an investor-focused presentation/event announcement, best fitting the Investor Presentation (IP) category.
2026-04-23 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.